Phase I trial of S-1 plus Lapatinib in patients with HER-2 positive metastatic breast cancer

Trial Profile

Phase I trial of S-1 plus Lapatinib in patients with HER-2 positive metastatic breast cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2018

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Lapatinib (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Feb 2018 Status changed from recruiting to completed.
    • 25 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top